Bayer Accused of ‘Pay to Appeal Scheme’ by Roundup Lawyers
- Company defends deal that pays Georgia doctor to appeal ruling
- Goal is to get Supreme Court to issue game-changing decision
Photographer: Daniel Acker/Bloomberg
This article is for subscribers only.
Bayer AG’s strategy to get a favorable ruling in its Roundup litigation is a manufactured “pay-to-appeal scheme” that will erode the U.S. system of justice if it’s permitted, plaintiffs’ lawyers said in a letter to a court.
Lawyers who are helping lead the nationwide litigation over allegations that the weed killer causes cancer responded Thursday to a deal Bayer entered into that essentially pays a Georgia man to keep fighting the company in court.